Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC. Read the official filing
Filing timeline
BuySaleEric Benevich
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eric Benevich: trading record in brief
Eric Benevich, listed as senior executive, appears in our data through filings on Neurocrine Biosciences Inc shares, published by SEC (Form 4). Between 16 August 2021 and 11 September 2026, the trades on record add up to 29 filings.
Sales make up the whole of the open-market record (12 sales, €3.0M). Other entries cover 2 share grants and 15 option exercises. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 15 September 2026: a share grant, in Neurocrine Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Eric Benevich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
6,275 shares0Common StockSEC:0001643653-26-000018:0
3,386 shares@ US$156.22Common StockSEC:0001643653-26-000018:1
3,194 shares@ US$43.240.0009% mcap1.4% of flowCommon StockSEC:0001643653-26-000016:0
2,154 shares@ US$154.610.0021% mcap3.3% of flowCommon StockSEC:0001643653-26-000016:1
2,005 shares0Common StockSEC:0001643653-26-000011:0
2,294 shares0Common StockSEC:0001643653-26-000008:0
12,830 shares@ US$35.990.0028% mcap22.5% of flowCommon StockSEC:0001643653-26-000005:0
5,970 shares@ US$35.992.0% of flowCommon StockSEC:0001643653-25-000007:0
5,970 shares@ US$151.73888.5% of flowCommon StockSEC:0001643653-25-000007:1
2,083 shares0Common StockSEC:0000914475-25-000057:0
1,860 shares0Common StockSEC:0000914475-25-000047:0
2,294 shares0Common StockSEC:0000914475-25-000021:0
7,231 shares@ US$81.496.0% of flowCommon StockSEC:0000914475-24-000111:0
5,479 shares@ US$79.024.3% of flowCommon StockSEC:0000914475-24-000096:0
53,143 shares@ US$43.2423.0% of flowCommon StockSEC:0000914475-24-000082:0
1,098 shares@ US$133.01491.5% of flowCommon StockSEC:0000914475-24-000068:0
1,280 shares@ US$142.11721.8% of flowCommon StockSEC:0000914475-24-000044:0
1,207 shares@ US$140.78441.7% of flowCommon StockSEC:0000914475-24-000023:0
1,600 shares@ US$107.39751.7% of flowCommon StockSEC:0001209191-23-047128:0
1,280 shares@ US$105.62561.4% of flowCommon StockSEC:0001209191-23-007907:0
1,207 shares@ US$109.95051.3% of flowCommon StockSEC:0001209191-23-006259:0
400 shares@ US$43.240.2% of flowCommon StockSEC:0001209191-23-002829:0
400 shares@ US$125.000.5% of flowCommon StockSEC:0001209191-23-002829:1
22,162 shares@ US$41.789.7% of flowCommon StockSEC:0001209191-22-059245:0
24,593 shares@ US$41.7811.1% of flowCommon StockSEC:0001209191-22-056437:0
25 of 29 declarations
